(Q35967320)

11 August 2017

1 reference

title

The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs (English)

1 reference

11 August 2017

0 references

1

Yuta Shibamoto

1 reference

11 August 2017

Chikao Sugie

2

1 reference

11 August 2017

Masato Ito

series ordinal

3

1 reference

11 August 2017

Hiroyuki Ogino

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Expert Opinion on Pharmacotherapy

11 August 2017

published in

1 reference

11 August 2017

volume

5

1 reference

11 August 2017

issue

12

1 reference

11 August 2017

page(s)

2459-2467

1 reference

The Klaas Breur Lecture. Radiation, hypoxia and genetic stimulation: implications for future therapies

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Hypoxia in tumors: a paradigm for the approach to biochemical and physiologic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Phase Ia study of a hypoxic cell sensitizer doranidazole (PR-350) in combination with conventional radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

1-(5'-Fluoro-6'-hydroxy-5',6'-dihydrouracil-5'-yl)-5-fluorouracil, a novel N(1)-C(5)-linked dimer that releases 5-fluorouracil by radiation activation under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

In vivo evaluation of a novel antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Optimization of the auxiliary ligand shell of Cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.12.2459

10.1517/14656566.5.12.2459

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference